uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection
Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.;Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden..
Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.;Lund Univ, Dept Clin Sci, Respiratory Med & Allergol, Lund, Sweden..
Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden..
Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.;Lund Univ, Dept Clin Sci, Respiratory Med & Allergol, Lund, Sweden..
Show others and affiliations
2016 (English)In: Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, E-ISSN 1460-2091, Vol. 71, no 1, 170-180 p.Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Objectives:Increasing resistance to antibiotics makes antimicrobial peptides interesting as novel therapeutics. Here, we report on studies of the peptide NLF20 (NLFRKLTHRLFRRNFGYTLR), corresponding to an epitope of the D helix of heparin cofactor II (HCII), a plasma protein mediating bacterial clearance. Methods: Peptide effects were evaluated by a combination of in vitro and in vivo methods, including antibacterial, anti-inflammatory and cytotoxicity assays, fluorescence and electron microscopy, and experimental models of endotoxin shock and Pseudomonas aeruginosa sepsis. Results: The results showed that NLF20 displayed potent antimicrobial effects against the Gram-negative bacteria Escherichia coli and P. aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus and the fungi Candida albicans and Candida parapsilosis. Importantly, this antimicrobial effect was retained in human blood, particularly for P. aeruginosa. Fluorescence and electron microscopy studies showed that the peptide exerted membrane-breaking effects. In an animal model of P. aeruginosa sepsis, NLF20 reduced bacterial levels, resulting in improved survival. Reduced mortality was also observed in experimental animal models of endotoxin shock, which was paralleled with modulated IFN-gamma, IL-10 and coagulation responses. Conclusions: Together, these results indicate that functional epitopes of HCII may have therapeutic potential against bacterial infection.

Place, publisher, year, edition, pages
2016. Vol. 71, no 1, 170-180 p.
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-282654DOI: 10.1093/jac/dkv322ISI: 000371238100026OAI: oai:DiVA.org:uu-282654DiVA: diva2:917444
Funder
Swedish Research Council, 2012-1842, 2012-1883Knut and Alice Wallenberg FoundationThe Crafoord FoundationTorsten Söderbergs stiftelseSwedish Foundation for Strategic Research
Available from: 2016-04-06 Created: 2016-04-06 Last updated: 2017-11-30

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Malmsten, Martin

Search in DiVA

By author/editor
Malmsten, Martin
By organisation
Department of Pharmacy
In the same journal
Journal of Antimicrobial Chemotherapy
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 189 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf